McCall McPherson talks with a medical expert about hormone replacement therapy. Starting estrogen within six years of menopause cuts cardiovascular disease risk by 30 to 50 percent, more effectively than statins or aspirin. Cardiologists rarely prescribe it despite heart disease being the leading killer of women.
And now, didn't a recent study come out, I think, in spring of this year that really showed it could, if you start estrogen replacement therapy early, that it could reduce your risk of cardiac events?
Yeah. I mean, we have dozens of studies at this point, randomized controlled trials and observational studies that have shown us that if you start HRT within about six years of menopause onset, you will see a 30 to 50% reduced risk of cardiovascular disease, which is the number one killer of men and women. It's the number one killer. One in three women will die of heart disease. Women aren't afraid enough of heart disease, and they're a little bit too, too afraid of other things, like breast cancer. In my opinion, heart disease is what's killing us. And, you know, there is not a single drug out there that will reduce your risk of heart disease the same way that estrogen will. There's not one single drug. And that includes your statins, that includes your aspirin, that even includes your, you know, like, all kinds of things. Any drugs that are out there are not reducing your risk the same way estrogen does. And yet even the cardiologists don't think about or use estrogen, which they should.